Marijuana Inc acquires exclusive worldwide marketing rights for proprietary cannabinoid medicinals 

Marijuana Inc acquires exclusive worldwide marketing rights for proprietary cannabinoid medicinals

Nov 05, 2012 (Menafn - M2 EQUITYBITES via COMTEX) --Hemp Inc (pinksheets:HEMP) said today that its subsidiary, Marijuana, Inc, has signed a 20-year agreement for the worldwide marketing rights to cannabinoid medicinals using a uniquely effective and safe delivery system.

This unique, proprietary system uses sublingual delivery by way of a pleasant tasting lozenge, instead of delivering the products through digestion or the lungs.

Under agreement, financial details of which were not available, Marijuana has the exclusive worldwide marketing rights to rapid onset products derived from cannabis or hemp and containing THC and/or CBD.

The terms of exclusivity are for three years and rights to market non-exclusively continue for 20 years. Marketing efforts will begin in Canada, the company said.

The company said that the initial product rollout features a patent pending coconut oil based lozenge that has been tested in Canada, with results showing that the lozenges provide a rapid onset time.

Comments on this story may be sent to info@m2.com

(C)1994-2012 M2 COMMUNICATIONS http://www.m2.com